The FDA accepted a resubmitted new drug application for reproxalap, a first-in-class investigational topical therapy for dry ...

AbbVie is seeking a new way to fight chronic lymphocytic leukemia by combining its oncology drug Venclexta with another ...

After a decade of development, a Kansas City-based pharmaceutical company is on the brink of submitting its ADHD medication ...

The new guidelines aim to streamline India’s drug approvals, improve transparency, and align regulatory practices with global ...

Shares of Zymeworks were higher after the Food and Drug Administration cleared the company's investigational new drug application for its treatment for liver cancer. The stock rose 8.5%, to $14.46, in ...

Johnson & Johnson (NYSE:JNJ) is one of the best trade‑war resistant stocks to buy now. On July 21, 2025, J&J submitted a New ...

Under the Inflation Reduction Act, medications with the same active ingredient will be treated as the same drug for price ...

The submission is supported by four Phase III clinical trials, which showed that icotrokinra demonstrated significant skin ...

Potential NIH and FDA cuts could lower the number of new drugs that come to market in the next three decades, according to a ...

Alphamab Oncology ( (HK:9966) ) has shared an update. Alphamab Oncology announced that its Investigational New Drug application for JSKN022, a novel bispecific antibody-drug conjugate targeting PD-L1 ...

The U.S. Food and Drug Administration has approved PTC Therapeutics' oral drug to treat a rare inherited metabolic disorder ...

Each year, the FDA approves a wide range of medications that help shape the future of medicine in the U.S. These include ...